KOOL - Cesca Therapeutics Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 540.67M
Enterprise Value 335.29M
Trailing P/E -0.93
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.80
Price/Book (mrq)1.27
Enterprise Value/Revenue 32.43
Enterprise Value/EBITDA 6-5.68

Financial Highlights

Fiscal Year
Fiscal Year Ends Jun 30, 2017
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin -200.31%
Operating Margin (ttm)-48.47%
Management Effectiveness
Return on Assets (ttm)-9.09%
Return on Equity (ttm)-92.20%
Income Statement
Revenue (ttm)14.53M
Revenue Per Share (ttm)1.63
Quarterly Revenue Growth (yoy)17.50%
Gross Profit (ttm)5.84M
Net Income Avi to Common (ttm)-29.09M
Diluted EPS (ttm)-4.41
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)3.62M
Total Cash Per Share (mrq)0.36
Total Debt (mrq)3.5M
Total Debt/Equity (mrq)11.35
Current Ratio (mrq)2.47
Book Value Per Share (mrq)3.21
Cash Flow Statement
Operating Cash Flow (ttm)-7.21M
Levered Free Cash Flow (ttm)-6.87M

Trading Information

Stock Price History
Beta 0.36
52-Week Change 334.12%
S&P500 52-Week Change 319.52%
52 Week High 36.4400
52 Week Low 32.4100
50-Day Moving Average 33.7066
200-Day Moving Average 33.3514
Share Statistics
Avg Vol (3 month) 3142.66k
Avg Vol (10 day) 347.36k
Shares Outstanding 59.95M
Float 1.69M
% Held by Insiders 168.59%
% Held by Institutions 112.44%
Shares Short 3263.42k
Short Ratio 31.13
Short % of Float 39.26%
Shares Short (prior month) 3295.16k
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/20
Last Split Date 3Mar 7, 2016